Trials / Completed
CompletedNCT00276328
Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in Adults
Efficacy of Diosmectite (Smecta®) in the Treatment of Acute Diarrhoea in Adults. A Multicentre, Randomised, Double Blind, Placebo Controlled, Parallel Groups Study.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 346 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate whether Smecta® is more effective than placebo with respect to time to recovery following an acute diarrhoea episode.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diosmectite (Smecta®) |
Timeline
- Start date
- 2005-01-01
- Completion
- 2006-07-01
- First posted
- 2006-01-13
- Last updated
- 2020-04-28
Locations
31 sites across 2 countries: Morocco, Tunisia
Source: ClinicalTrials.gov record NCT00276328. Inclusion in this directory is not an endorsement.